{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:02:38Z","timestamp":1787169758405,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Surgically accessible brain metastases are treated through microsurgical removal followed by radiation therapy, resulting in improved progression-free and overall survival. Some patients experience recurrence, prompting the need for effective management strategies. Despite the prevalence of recurrence, there remains a gap in the literature regarding the outcomes of patients undergoing re-resection of brain metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to comprehensively characterize clinical, radiological, histopathological, and treatment-related aspects, along with outcomes, for patients undergoing re-resection of locally and distantly recurrent brain metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-center retrospective cohort study, including patients who underwent secondary brain metastasis resection following prior primary brain metastasis resection and irradiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 60 patients, 41 (68.3%) had local recurrences, and 19 (31.7%) had distant recurrences. Median intracranial progression-free survival was 7.7 months [95% CI: 6.5\u201311.2], time to re-resection was 11.6 months [95% CI: 9.1\u201315.3], and overall survival was 30.8 months [95% CI: 20.4\u201349.5]. Non-small cell lung cancer (NSCLC) was the most common primary tumor. Post-initial resection treatments included radiation alone (31.7%), radiation plus chemotherapy (25.0%), radiation plus targeted therapy (15.0%), and radiation plus immunotherapy (28.3%). Cavity irradiation was performed in 46 patients (76.7%) and whole brain radiation in 14 (23.3%). Post-re-resection treatments varied: 21 patients (35.0%) received best supportive care, 15 (25.0%) radiation only, 12 (20.0%) systemic therapy only, and 12 (20.0%) both radiation and systemic therapy. Independent risk factors for shorter overall survival included non-breast cancer histology, pre-re-resection tumor volume\u2009&gt;\u20099 mL, pre-re-resection Karnofsky Performance Status\u2009\u2264\u200960%, and presence of vital tumor cells at re-resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Brain metastasis resection of local and distant recurrences is feasible and a treatment option for selected patients with good clinical performance status. This study underscores the potential role of re-resection in brain metastasis. Further research to improve patient selection and treatment algorithms is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-13677-0","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:43:32Z","timestamp":1748778212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Re-resection of brain metastases \u2013 outcomes of an institutional cohort study and literature review"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-0584","authenticated-orcid":false,"given":"David","family":"Wasilewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3762-1014","authenticated-orcid":false,"given":"Zoe","family":"Shaked","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalena","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyer","family":"Roohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Schlaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Misch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Capper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Onken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vajkoczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,1]]},"reference":[{"issue":"1","key":"13677_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","volume":"20","author":"A Boire","year":"2020","unstructured":"Boire A, Brastianos PK, Garzia L, Valiente MN. Brain metastasis. Rev Cancer. 2020;20(1):4\u201311. https:\/\/doi.org\/10.1038\/s41568-019-0220-y. Epub 2019 Nov 28.PMID: 31780784.","journal-title":"Rev Cancer"},{"key":"13677_CR2","doi-asserted-by":"publisher","unstructured":"Sammons S, Van Swearingen AED, Chung C, Anders CK. Advances in the management of breast cancer brain metastases. Neurooncol Adv. 2021;3(Suppl 5):v63\u201374. https:\/\/doi.org\/10.1093\/noajnl\/vdab119. eCollection 2021 Nov.PMID: 34859234.","DOI":"10.1093\/noajnl\/vdab119"},{"issue":"10","key":"13677_CR3","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/neuonc\/noac118.PMID","volume":"24","author":"AA Aizer","year":"2022","unstructured":"Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY. Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro Oncol. 2022;24(10):1613\u201346. https:\/\/doi.org\/10.1093\/neuonc\/noac118. PMID: 35762249.","journal-title":"Neuro Oncol"},{"issue":"11","key":"13677_CR4","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","volume":"32","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M, Preusser M; EANO Executive Board and ESMO Guidelines Committee. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol. 2021;32(11):1332\u201347. https:\/\/doi.org\/10.1016\/j.annonc.2021.07.016. Epub 2021 Aug 6.PMID: 34364998.","journal-title":"Ann Oncol"},{"issue":"5","key":"13677_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff DJ. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. Clin Oncol. 2022;40(5):492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314. Epub 2021 Dec 21.PMID: 34932393.","journal-title":"Clin Oncol"},{"key":"13677_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.radonc.2019.08.024","volume":"142","author":"ZZ Akanda","year":"2020","unstructured":"Akanda ZZ, Hong W, Nahavandi S, Haghighi N, Phillips C, Kok DL. Post-operative stereotactic radiosurgery following excision of brain metastases: a systematic review and meta-analysis. Radiother Oncol. 2020;142:27\u201335. https:\/\/doi.org\/10.1016\/j.radonc.2019.08.024. Epub 2019 Sep 25.PMID: 31563407.","journal-title":"DL Radiother Oncol"},{"issue":"2","key":"13677_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3171\/2009.11.JNS09659.PMID","volume":"113","author":"AJ Patel","year":"2010","unstructured":"Patel AJ, Suki D, Hatiboglu MA, Abouassi H, Shi W, Wildrick DM, Lang FF, Sawaya R. Factors influencing the risk of local recurrence after resection of a single brain metastasis. J Neurosurg. 2010;113(2):181\u20139. https:\/\/doi.org\/10.3171\/2009.11.JNS09659. PMID: 20035574.","journal-title":"J Neurosurg"},{"issue":"17","key":"13677_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.280.17.1485.PMID","volume":"280","author":"RA Patchell","year":"1998","unstructured":"Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280(17):1485\u20139. https:\/\/doi.org\/10.1001\/jama.280.17.1485. PMID: 9809728.","journal-title":"JAMA"},{"issue":"1","key":"13677_CR9","doi-asserted-by":"publisher","first-page":"vdac033","DOI":"10.1093\/noajnl\/vdac033","volume":"4","author":"DT Krist","year":"2022","unstructured":"Krist DT, Naik A, Thompson CM, Kwok SS, Janbahan M, Olivero WC, Hassaneen W. Management of brain metastasis. Surgical resection versus stereotactic radiotherapy: a meta-analysis. Neurooncol Adv. 2022;4(1):vdac033. https:\/\/doi.org\/10.1093\/noajnl\/vdac033. eCollection 2022 Jan-Dec.PMID: 35386568.","journal-title":"Neurooncol Adv"},{"issue":"4","key":"13677_CR10","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3171\/jns.1995.83.4.0600.PMID","volume":"83","author":"RK Bindal","year":"1995","unstructured":"Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor SH. Reoperation for recurrent metastatic brain tumors. J Neurosurg. 1995;83(4):600\u20134. https:\/\/doi.org\/10.3171\/jns.1995.83.4.0600. PMID: 7674007.","journal-title":"J Neurosurg"},{"issue":"4","key":"13677_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3171\/2009.4.JNS09246.PMID","volume":"111","author":"H Kano","year":"2009","unstructured":"Kano H, Kondziolka D, Zorro O, Lobato-Polo J, Flickinger JC, Lunsford LD. The results of resection after stereotactic radiosurgery for brain metastases. J Neurosurg. 2009;111(4):825\u201331. https:\/\/doi.org\/10.3171\/2009.4.JNS09246. PMID: 19425892.","journal-title":"J Neurosurg"},{"issue":"10","key":"13677_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00701-013-1821-y","volume":"155","author":"G Schackert","year":"2013","unstructured":"Schackert G, Schmiedel K, Lindner C, Leimert M, Kirsch M. Surgery of recurrent brain metastases: retrospective analysis of 67 patients. Acta Neurochir (Wien). 2013;155(10):1823\u201332. https:\/\/doi.org\/10.1007\/s00701-013-1821-y. Epub 2013 Aug 3.PMID: 23913109.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"13677_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/02688697.2017.1302072","volume":"31","author":"O Kennion","year":"2017","unstructured":"Kennion O, Holliman D. Outcome after craniotomy for recurrent cranial metastases. J Neurosurg. 2017;31(3):369\u201373. https:\/\/doi.org\/10.1080\/02688697.2017.1302072. Epub 2017 Mar 14.PMID: 28290227.","journal-title":"J Neurosurg"},{"key":"13677_CR14","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1016\/j.wneu.2022.08.066","volume":"167","author":"IA Tewarie","year":"2022","unstructured":"Tewarie IA, Hulsbergen AFC, Jessurun CAC, Rendon LF, Mekary RA, Smith TR, Broekman MLD. Risk factors of second local recurrence in surgically treated recurrent brain metastases: an exploratory analysis. World Neurosurg. 2022;167:e639-47. https:\/\/doi.org\/10.1016\/j.wneu.2022.08.066. Epub 2022 Aug 24.PMID: 36028114.","journal-title":"World Neurosurg"},{"issue":"1","key":"13677_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12885-022-09317-6.PMID","volume":"22","author":"ST J\u00fcnger","year":"2022","unstructured":"J\u00fcnger ST, Meissner AK, Kocher M, Goldbrunner R, Grau S. Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting. BMC Cancer. 2022;22(1):275. https:\/\/doi.org\/10.1186\/s12885-022-09317-6. PMID: 35291972.","journal-title":"BMC Cancer"},{"key":"13677_CR16","doi-asserted-by":"publisher","unstructured":"Li AY, et al. Association of brain metastases with survival in patients with limited or stable extracranial disease: a systematic review and meta-analysis.\u00a0JAMA Netw Open. 2023;6(2):e235008. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.5008. PMID:\u00a036821113.","DOI":"10.1001\/jamanetworkopen.2023.5008"},{"key":"13677_CR17","doi-asserted-by":"publisher","unstructured":"Wasilewski D, Radke J, Xu R, Raspe M, Trelinska-Finger A, Rosenstock T, Poeser P, Schumann E, Lindner J, Heppner F, Kaul D, Suttorp N, Vajkoczy P, Frost N, Onken J. Effectiveness of immunecheckpoint inhibition vs chemotherapy in combination with radiation therapyamong patients with non-small cell lung cancer and brain metastasis undergoing neurosurgical resection. JAMA Netw Open. 2022;5(4):e229553. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.9553. PMID: 35486401.","DOI":"10.1001\/jamanetworkopen.2022.9553"},{"issue":"1","key":"13677_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-014-3090-8","volume":"147","author":"N Hayashi","year":"2014","unstructured":"Hayashi N, Masuda N, Takashima S, Nakamura R, Watanabe K, Kanbayashi C, Ishida M, Hozumi Y, Tsuneizumi M, Kondo N, Naito Y, Honda Y, Matsui A, Fujisawa T, Oshitanai R, Yasojima H, Tokuda Y, Saji S, Iwata H. Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis. Breast Cancer Res Treat. 2014;147(1):103\u201312. https:\/\/doi.org\/10.1007\/s10549-014-3090-8. Epub 2014 Aug 9.PMID: 25106661.","journal-title":"Breast Cancer Res Treat"},{"key":"13677_CR19","doi-asserted-by":"publisher","unstructured":"Das S, Faruqi S, Nordal R, Starreveld Y, Kelly J, Bowden G, Amanie J, Fairchild A, Lim G, Loewen S, Rowe L, Wallace C, Ghosh S, Patel S. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases. BMC Cancer. 2022;22(1):1368. https:\/\/doi.org\/10.1186\/s12885-022-10480-z. PMID: 3658562.","DOI":"10.1186\/s12885-022-10480-z"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13677-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13677-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13677-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:43:33Z","timestamp":1748778213000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13677-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13677"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13677-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local institutional review board (EA1\/399\/20). Due to the retrospective design of the study, written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Felix Ehret has received honoraria and travel support from ZAP Surgical Systems, Inc., and acknowledges research funding from the German Cancer Aid and Accuray, Inc., all unrelated to the submitted work. All other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"973"}}